Jean-Louis Constanza is one of the founders, and Chief Clinical and Development Officer, of Wandercraft. In the last 5 years he worked with many medical teams to adapt Wandercraft’s exo, the first autonomous walk robotic exoskeleton, to the needs of Neuro and PMR institutions and their patients. He has a 30 years experience in digital and robotics industries and start-ups.
Autonomous Walk Exoskeleton: first learnings from clinical trials and expectations
The first autonomous walk exoskeleton has been tested since 2017 and is now being used for patient treatment in Europe. The seminar aim is to present and discuss preliminary learnings, on-going clinical studies and expected impact on treatment for stroke patients and patients with severe gait disorder.
EVEN MORE SEMINARS
Rosanne Tyas Royal Hospital for Neuro-disability
Music Therapy has much to offer: An overview of the effects of music therapy across different domains in neuro-disability.
Dr Jenny Brooks The ABI Team
Neurobehavioural Rehabilitation In The Community
Dr Najma Khan-Bourne King’s College Hospital NHS Foundation Trust
Neuropsychological evaluation and formulation in acute stroke rehabilitation
Dr Nick Davis Manchester Metropolitan University
Towards precision treatment and enhancement with non-invasive brain stimulation
Shauna Kearney Birmingham Children’s Hospital
The neuropsychology of Inherited metabolic disorders